# Marcus & Millichap, Inc.: financial statements, quarterly

MMI · NYSE · CIK 1578732 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mmi.md) · [Financials](/companies/mmi/financials.md) · [Filings](/companies/mmi/filings.md) · [Insiders](/companies/mmi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/mmi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [162](/filings/0001578732-24-000053.md) | [166 d](/filings/0001628280-26-012419.md) | [129](/filings/0001578732-25-000031.md) | [158](/filings/0001578732-25-000040.md) | [169](/filings/0001628280-25-050707.md) | [240 d](/filings/0001628280-26-012419.md) | [145](/filings/0001628280-26-032300.md) | [172](/filings/0001628280-26-054439.md) | [194](/filings/0001628280-25-050707.md) | [244 d](/filings/0001628280-26-012419.md) | [171](/filings/0001628280-26-032300.md) | [203](/filings/0001628280-26-054439.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | [69.2](/filings/0001578732-24-000053.md) | [74.7 d](/filings/0001628280-26-012419.md) | [68.9](/filings/0001578732-25-000031.md) | [65.0](/filings/0001578732-25-000040.md) | [70.7](/filings/0001628280-25-050707.md) | [76.3 d](/filings/0001628280-26-012419.md) | [71.6](/filings/0001628280-26-032300.md) | [71.6](/filings/0001628280-26-054439.md) | [72.5](/filings/0001628280-25-050707.md) | [70.7 d](/filings/0001628280-26-012419.md) | [71.2](/filings/0001628280-26-032300.md) | [71.7](/filings/0001628280-26-054439.md) |
| Operating income | $m | [(15.4)](/filings/0001578732-24-000053.md) | [(17.2) d](/filings/0001628280-26-012419.md) | [(20.1)](/filings/0001578732-25-000031.md) | [(8.0)](/filings/0001578732-25-000040.md) | [(11.5)](/filings/0001628280-25-050707.md) | [6.7 d](/filings/0001628280-26-012419.md) | [(17.7)](/filings/0001628280-26-032300.md) | [(9.0)](/filings/0001628280-26-054439.md) | [(2.4)](/filings/0001628280-25-050707.md) | [15.4 d](/filings/0001628280-26-012419.md) | [(5.8)](/filings/0001628280-26-032300.md) | [2.2](/filings/0001628280-26-054439.md) |
| Interest expense | $m | [0.2](/filings/0001578732-23-000048.md) | [0.2 d](/filings/0001578732-24-000009.md) | [0.2](/filings/0001578732-24-000029.md) | [0.2](/filings/0001578732-25-000040.md) | [0.2](/filings/0001628280-25-050707.md) | [0.2 d](/filings/0001628280-26-012419.md) | [0.2](/filings/0001628280-26-032300.md) | [0.2](/filings/0001628280-26-054439.md) | [0.2](/filings/0001628280-25-050707.md) | [0.2 d](/filings/0001628280-26-012419.md) | [0.2](/filings/0001628280-26-032300.md) | [0.1](/filings/0001628280-26-054439.md) |
| Income tax | $m | [(2.0)](/filings/0001578732-24-000053.md) | [(1.5) d](/filings/0001628280-26-012419.md) | [(4.7)](/filings/0001578732-25-000031.md) | [2.1](/filings/0001578732-25-000040.md) | [(1.0)](/filings/0001628280-25-050707.md) | [2.9 d](/filings/0001628280-26-012419.md) | [(9.5)](/filings/0001628280-26-032300.md) | [7.3](/filings/0001628280-26-054439.md) | [1.2](/filings/0001628280-25-050707.md) | [5.9 d](/filings/0001628280-26-012419.md) | [0.9](/filings/0001628280-26-032300.md) | [2.4](/filings/0001628280-26-054439.md) |
| Net income | $m | [(9.2)](/filings/0001578732-24-000053.md) | [(10.2) d](/filings/0001628280-26-012419.md) | [(10.0)](/filings/0001578732-25-000031.md) | [(5.5)](/filings/0001578732-25-000040.md) | [(5.4)](/filings/0001628280-25-050707.md) | [8.5 d](/filings/0001628280-26-012419.md) | [(4.4)](/filings/0001628280-26-032300.md) | [(11.0)](/filings/0001628280-26-054439.md) | [0.2](/filings/0001628280-25-050707.md) | [13.3 d](/filings/0001628280-26-012419.md) | [(3.1)](/filings/0001628280-26-032300.md) | [3.9](/filings/0001628280-26-054439.md) |
| Diluted EPS | $ per share | [(0.24)](/filings/0001578732-24-000053.md) | not reported | [(0.26)](/filings/0001578732-25-000031.md) | [(0.14)](/filings/0001578732-25-000040.md) | [(0.14)](/filings/0001628280-25-050707.md) | not reported | [(0.11)](/filings/0001628280-26-032300.md) | [(0.28)](/filings/0001628280-26-054439.md) | [0.01](/filings/0001628280-25-050707.md) | not reported | [(0.08)](/filings/0001628280-26-032300.md) | [0.10](/filings/0001628280-26-054439.md) |
| Basic EPS | $ per share | [(0.24)](/filings/0001578732-24-000053.md) | not reported | [(0.26)](/filings/0001578732-25-000031.md) | [(0.14)](/filings/0001578732-25-000040.md) | [(0.14)](/filings/0001628280-25-050707.md) | not reported | [(0.11)](/filings/0001628280-26-032300.md) | [(0.28)](/filings/0001628280-26-054439.md) | [0.01](/filings/0001628280-25-050707.md) | not reported | [(0.08)](/filings/0001628280-26-032300.md) | [0.10](/filings/0001628280-26-054439.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [390](/filings/0001578732-23-000048.md) | [394](/filings/0001578732-25-000015.md) | [344](/filings/0001578732-24-000029.md) | [344](/filings/0001578732-24-000045.md) | [357](/filings/0001578732-24-000053.md) | [410](/filings/0001628280-26-012419.md) | [325](/filings/0001578732-25-000031.md) | [302](/filings/0001578732-25-000040.md) | [310](/filings/0001628280-25-050707.md) | [309](/filings/0001628280-26-054439.md) | [245](/filings/0001628280-26-032300.md) | [271](/filings/0001628280-26-054439.md) |
| Total assets | $m | [882](/filings/0001578732-23-000048.md) | [878](/filings/0001578732-25-000015.md) | [827](/filings/0001578732-24-000029.md) | [825](/filings/0001578732-24-000045.md) | [834](/filings/0001578732-24-000053.md) | [870](/filings/0001628280-26-012419.md) | [802](/filings/0001578732-25-000031.md) | [792](/filings/0001578732-25-000040.md) | [812](/filings/0001628280-25-050707.md) | [827](/filings/0001628280-26-054439.md) | [755](/filings/0001628280-26-032300.md) | [766](/filings/0001628280-26-054439.md) |
| Current liabilities | $m | [103](/filings/0001578732-23-000048.md) | [105](/filings/0001578732-25-000015.md) | [92.6](/filings/0001578732-24-000029.md) | [93.1](/filings/0001578732-24-000045.md) | [113](/filings/0001578732-24-000053.md) | [133](/filings/0001628280-26-012419.md) | [86.2](/filings/0001578732-25-000031.md) | [87.0](/filings/0001578732-25-000040.md) | [113](/filings/0001628280-25-050707.md) | [121](/filings/0001628280-26-054439.md) | [92.5](/filings/0001628280-26-032300.md) | [92.8](/filings/0001628280-26-054439.md) |
| Total liabilities | $m | [233](/filings/0001578732-23-000048.md) | [233](/filings/0001578732-25-000015.md) | [201](/filings/0001578732-24-000029.md) | [199](/filings/0001578732-24-000045.md) | [216](/filings/0001578732-24-000053.md) | [239](/filings/0001628280-26-012419.md) | [184](/filings/0001578732-25-000031.md) | [184](/filings/0001578732-25-000040.md) | [210](/filings/0001628280-25-050707.md) | [224](/filings/0001628280-26-054439.md) | [186](/filings/0001628280-26-032300.md) | [187](/filings/0001628280-26-054439.md) |
| Shareholders' equity | $m | [649](/filings/0001578732-24-000053.md) | [645](/filings/0001628280-26-012419.md) | [626](/filings/0001578732-25-000040.md) | [627](/filings/0001628280-25-050707.md) | [618](/filings/0001628280-25-050707.md) | [631](/filings/0001628280-26-054439.md) | [618](/filings/0001628280-26-054439.md) | [608](/filings/0001628280-26-054439.md) | [602](/filings/0001628280-25-050707.md) | [603](/filings/0001628280-26-054439.md) | [569](/filings/0001628280-26-054439.md) | [579](/filings/0001628280-26-054439.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.7 d](/filings/0001578732-24-000053.md) | [14.7 d](/filings/0001628280-26-012419.md) | [(51.0)](/filings/0001578732-25-000031.md) | [0.9 d](/filings/0001578732-25-000040.md) | [15.2 d](/filings/0001628280-25-050707.md) | [56.7 d](/filings/0001628280-26-012419.md) | [(52.8)](/filings/0001628280-26-032300.md) | [21.0 d](/filings/0001628280-26-054439.md) | [52.2 d](/filings/0001628280-25-050707.md) | [46.3 d](/filings/0001628280-26-012419.md) | [(27.6)](/filings/0001628280-26-032300.md) | [22.2 d](/filings/0001628280-26-054439.md) |
| Capital expenditure | $m | [2.2 d](/filings/0001578732-24-000053.md) | [1.7 d](/filings/0001628280-26-012419.md) | [2.6](/filings/0001578732-25-000031.md) | [1.7 d](/filings/0001578732-25-000040.md) | [2.0 d](/filings/0001628280-25-050707.md) | [1.5 d](/filings/0001628280-26-012419.md) | [1.5](/filings/0001628280-26-032300.md) | [1.7 d](/filings/0001628280-26-054439.md) | [2.3 d](/filings/0001628280-25-050707.md) | [2.4 d](/filings/0001628280-26-012419.md) | [3.0](/filings/0001628280-26-032300.md) | [0.9 d](/filings/0001628280-26-054439.md) |
| Dividends paid | $m | [0.1 d](/filings/0001578732-24-000053.md) | [9.7 d](/filings/0001628280-26-012419.md) | [0.6](/filings/0001578732-25-000031.md) | [9.7 d](/filings/0001578732-25-000040.md) | [0.2 d](/filings/0001628280-25-050707.md) | [9.7 d](/filings/0001628280-26-012419.md) | [0.7](/filings/0001628280-26-032300.md) | [9.9 d](/filings/0001628280-26-054439.md) | [0.2 d](/filings/0001628280-25-050707.md) | [9.8 d](/filings/0001628280-26-012419.md) | [0.8](/filings/0001628280-26-032300.md) | [9.6 d](/filings/0001628280-26-054439.md) |
| Share repurchases | $m | [0.0 d](/filings/0001578732-24-000053.md) | [4.5 d](/filings/0001628280-26-012419.md) | [0.6](/filings/0001578732-25-000031.md) | [0.0 d](/filings/0001578732-25-000040.md) | [0.0 d](/filings/0001628280-25-050707.md) | [0.2 d](/filings/0001628280-26-012419.md) | [0.4](/filings/0001628280-26-032300.md) | [7.0 d](/filings/0001628280-26-054439.md) | [0.6 d](/filings/0001628280-25-050707.md) | [17.4 d](/filings/0001628280-26-012419.md) | [24.9](/filings/0001628280-26-032300.md) | [0.5 d](/filings/0001628280-26-054439.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [40.3](/filings/0001578732-23-000048.md) | [39.2](/filings/0001578732-24-000029.md) | [38.5](/filings/0001578732-24-000045.md) | [38.5](/filings/0001578732-24-000053.md) | [38.4](/filings/0001578732-25-000031.md) | [38.7](/filings/0001578732-25-000040.md) | [38.8](/filings/0001628280-25-050707.md) | [38.9](/filings/0001628280-26-032300.md) | [39.0](/filings/0001628280-26-054439.md) | [39.2](/filings/0001628280-25-050707.md) | [38.2](/filings/0001628280-26-032300.md) | [38.0](/filings/0001628280-26-054439.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 37,871,003 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054439.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.